Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A21223 | 25469790 | J Gastroenterol Hepatol | Anti-adipocyte antibody response in patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A21226 | 25469019 | World J Gastroenterol | Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications. | 2014 | Details |
| A21228 | 25469014 | World J Gastroenterol | Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development. | 2014 | Details |
| A21244 | 25458829 | Metabolism | The addition of medium-chain triglycerides to a purified fish oil-based diet alters inflammatory profiles in mice. | 2014 | Details |
| A21248 | 25456789 | Med Hypotheses | Nonalcoholic fatty liver disease (NAFLD)--is it a new marker of hyporesponsiveness to recombinant human erythropoietin in patients that are on chronic hemodialysis? | 2014 | Details |
| A21250 | 25456097 | Metabolism | Leptin in nonalcoholic fatty liver disease: a narrative review. | 2014 | Details |
| A21255 | 25453513 | J Med Food | Green Tea Lowers Hepatic COX-2 and Prostaglandin E2 in Rats with Dietary Fat-Induced Nonalcoholic Steatohepatitis. | 2014 | Details |
| A21264 | 25450203 | J Hepatol | Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. | 2014 | Details |
| A21267 | 25446569 | Eur J Pharmacol | Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway. | 2014 | Details |
| A21269 | 25445398 | J Hepatol | TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess. | 2014 | Details |
| A21272 | 25443620 | Liver Int | The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation. | 2015 | Details |
| A21274 | 25440222 | J Nutr Biochem | Pathophysiological basis for compromised health beyond generations: role of maternal high-fat diet and low-grade chronic inflammation. | 2014 | Details |
| A21280 | 25433921 | Dig Dis Sci | Fibromyalgia symptoms and cirrhosis. | 2014 | Details |
| A21283 | 27356367 | Bull Acad Natl Med | [Metabolic syndrome, non alcoholic hepatic steatopathy and hepatocellular carcinoma: so dangerous liaisons]. | 2014 | Details |
| A21297 | 25427048 | J Cardiovasc Med (Hagerstown) | Inflammatory bowel disease, liver diseases and endothelial function: is there a linkage? | 2015 | Details |
| A21303 | 25421042 | Mol Med Rep | Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model. | 2014 | Details |
| A21309 | 25415189 | PLoS One | Transcriptome analysis on the inflammatory cell infiltration of nonalcoholic steatohepatitis in bama minipigs induced by a long-term high-fat, high-sucrose diet. | 2014 | Details |
| A21322 | 25406833 | J Transl Med | Hepatoprotective and antioxidant activities of extracts from Salvia-Nelumbinis naturalis against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet in mice. | 2014 | Details |
| A21327 | 25404123 | Drugs R D | In vivo efficacy study of milk thistle extract (ETHIS-094™) in STAM™ model of nonalcoholic steatohepatitis. | 2014 | Details |
| A21342 | 25389366 | Am J Physiol Endocrinol Metab | CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice. | 2014 | Details |
| A21345 | 25386083 | World J Gastroenterol | Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies. | 2014 | Details |
| A21361 | 25376397 | Obesity (Silver Spring) | The role of small heterodimer partner in nonalcoholic fatty liver disease improvement after sleeve gastrectomy in mice. | 2014 | Details |
| A21364 | 25372401 | PLoS One | Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. | 2014 | Details |
| A21366 | 25371540 | J Endocrinol | Liver immune responses to inflammatory stimuli in a diet-induced obesity model of zebrafish. | 2014 | Details |
| A21373 | 25367327 | Food Funct | Effects of Callistephus chinensis flower polyphones on improving metabolic disorders in high-fat diet-induced mice. | 2014 | Details |
| A21377 | 25360830 | Med Sci Monit | Serum γ-glutamyltransferase level is associated with periodontal disease independent of drinking habits in Japanese adults. | 2014 | Details |
| A21378 | 25360469 | Oral Dis | A specific Streptococcus mutans strain aggravates non-alcoholic fatty liver disease. | 2014 | Details |
| A21383 | 25356831 | PLoS One | Protective role of plant sterol and stanol esters in liver inflammation: insights from mice and humans. | 2014 | Details |
| A21385 | 25356042 | World J Gastroenterol | Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation. | 2014 | Details |
| A21389 | 25353663 | Nutrients | Effects of dietary fat and saturated fat content on liver fat and markers of oxidative stress in overweight/obese men and women under weight-stable conditions. | 2014 | Details |
| A21391 | 25352871 | Afr Health Sci | Markers of liver function and inflammatory cytokines modulation by aerobic versus resisted exercise training for nonalcoholic steatohepatitis patients. | 2014 | Details |
| A21401 | 25348739 | J Sci Food Agric | Carnosic acid attenuates obesity-induced glucose intolerance and hepatic fat accumulation by modulating genes of lipid metabolism in C57BL/6J-ob/ob mice. | 2014 | Details |
| A21402 | 25347994 | J Pharmacol Exp Ther | M1 polarization bias and subsequent nonalcoholic steatohepatitis progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1-induced oxidative stress in obese mice. | 2014 | Details |
| A21412 | 25339829 | World J Gastroenterol | FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation. | 2014 | Details |
| A21425 | 25328713 | Int J Hepatol | Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease. | 2014 | Details |
| A21431 | 25324136 | Horm Res Paediatr | Non-alcoholic fatty liver and metabolic syndrome in children: a vicious circle. | 2014 | Details |
| A21434 | 25319795 | Int J Mol Med | Obesity increases histone H3 lysine 9 and 18 acetylation at Tnfa and Ccl2 genes in mouse liver. | 2014 | Details |
| A21437 | 25318054 | Int J Mol Sci | Effects of the olive-derived polyphenol oleuropein on human health. | 2014 | Details |
| A21438 | 25317840 | Food Funct | Lactobacillus plantarum NCU116 improves liver function, oxidative stress and lipid metabolism in rats with high fat diet induced non-alcoholic fatty liver disease. | 2014 | Details |
| A21447 | 25311610 | Nutr Res | Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A21450 | 25310404 | PLoS One | The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease. | 2014 | Details |
| A21454 | 25309079 | World J Gastroenterol | Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease. | 2014 | Details |
| A21470 | 25297827 | Hepatol Res | Human placental extract treatment for non-alcoholic steatohepatitis non-responsive to lifestyle intervention: A pilot study. | 2014 | Details |
| A21472 | 25296088 | Arq Gastroenterol | Ginseng, green tea or fibrate: valid options for nonalcoholic steatohepatitis prevention? | 2015 | Details |
| A21479 | 25292174 | Obesity (Silver Spring) | Obesity depresses the anti-inflammatory HSP70 pathway, contributing to NAFLD progression. | 2014 | Details |
| A21480 | 25291138 | J Clin Gastroenterol | Coffee and liver health. | 2015 | Details |
| A21490 | 25281859 | J Hepatol | Hematopoietic overexpression of Cyp27a1 reduces hepatic inflammation independently of 27-hydroxycholesterol levels in Ldlr(-/-) mice. | 2014 | Details |
| A21493 | 25281430 | Diabetes | WISP1 is a novel adipokine linked to inflammation in obesity. | 2014 | Details |
| A21504 | 25268946 | PLoS One | Carotid intima-media thickness is predicted by combined eotaxin levels and severity of hepatic steatosis at ultrasonography in obese patients with Nonalcoholic Fatty Liver Disease. | 2014 | Details |
| A21506 | 25267960 | J Gastrointestin Liver Dis | A potential treatment of non-alcoholic fatty liver disease with SIRT1 activators. | 2014 | Details |
| A21526 | 25253361 | Saudi J Gastroenterol | The effect of bariatric surgeries on nonalcoholic fatty liver disease. | 2015 | Details |
| A21551 | 25234945 | J Hepatol | Arginase 2 deficiency results in spontaneous steatohepatitis: a novel link between innate immune activation and hepatic de novo lipogenesis. | 2014 | Details |
| A21561 | 25229199 | Pathol Int | Japanese herbal medicines shosaikoto, inchinkoto, and juzentaihoto inhibit high-fat diet-induced nonalcoholic steatohepatitis in db/db mice. | 2014 | Details |
| A21569 | 25220580 | Sleep Med Rev | Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials. | 2014 | Details |
| A21575 | 25217800 | Exp Mol Pathol | Alcoholic and non-alcoholic steatohepatitis. | 2014 | Details |
| A21576 | 25216251 | PLoS One | IL-1 signaling in obesity-induced hepatic lipogenesis and steatosis. | 2014 | Details |
| A21589 | 25203709 | Zhonghua Gan Zang Bing Za Zhi | [Development and evaluation of a high-fat/high-fructose diet-induced nonalcoholic steatohepatitis mouse model]. | 2014 | Details |
| A21617 | 25183508 | Acta Physiol Hung | Naltrexone attenuates endoplasmic reticulum stress induced hepatic injury in mice. | 2014 | Details |
| A21623 | 25176122 | Aliment Pharmacol Ther | Association between aspirin use and the prevalence of nonalcoholic fatty liver disease: a cross-sectional study from the Third National Health and Nutrition Examination Survey. | 2014 | Details |
| A21630 | 25168691 | J Gastroenterol Hepatol | Use of non-invasive serum glycan markers to distinguish non-alcoholic steatohepatitis from simple steatosis. | 2015 | Details |
| A21641 | 25160499 | Br J Nutr | A high-protein diet is anti-steatotic and has no pro-inflammatory side effects in dyslipidaemic APOE2 knock-in mice. | 2014 | Details |
| A21650 | 25152980 | Ann Hepatol | Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease. | 2015 | Details |
| A21651 | 25152979 | Ann Hepatol | Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients. | 2015 | Details |
| A21659 | 25143715 | Clin Interv Aging | Nonalcoholic fatty liver disease (NAFLD) - a new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients. | 2014 | Details |
| A21662 | 25140521 | PLoS One | Associations between longer habitual day napping and non-alcoholic fatty liver disease in an elderly Chinese population. | 2014 | Details |
| A21665 | 25138963 | Endocrine | Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients. | 2014 | Details |
| A21668 | 25136608 | Biomed Res Int | Ruscogenin ameliorates experimental nonalcoholic steatohepatitis via suppressing lipogenesis and inflammatory pathway. | 2014 | Details |
| A21675 | 25128743 | Biochim Biophys Acta | Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison? | 2014 | Details |
| A21679 | 25126158 | Int J Clin Exp Med | Signal transductions and nonalcoholic fatty liver: a mini-review. | 2014 | Details |
| A21681 | 25125077 | Hepatology | Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. | 2015 | Details |
| A21683 | 25122558 | FASEB J | Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis. | 2014 | Details |
| A21693 | 25116118 | Planta Med | Ruscogenin protects against high-fat diet-induced nonalcoholic steatohepatitis in hamsters. | 2014 | Details |
| A21711 | 25102800 | Acta Dermatovenerol Croat | The linkage between psoriasis and non-alcoholic fatty liver disease: a literature review. | 2014 | Details |
| A21720 | 25092442 | J Transl Med | Is serum Interleukin-17 associated with early atherosclerosis in obese patients? | 2014 | Details |
| A21726 | 25089018 | J Gastroenterol Hepatol | Sophocarpine attenuates toll-like receptor 4 in steatotic hepatocytes to suppress pro-inflammatory cytokines synthesis. | 2015 | Details |
| A21731 | 25085644 | Am J Kidney Dis | CKD and nonalcoholic fatty liver disease. | 2014 | Details |
| A21739 | 25083076 | World J Gastroenterol | Role of liver biopsy in nonalcoholic fatty liver disease. | 2014 | Details |
| A21744 | 25074471 | Clin Sci (Lond) | CXCR4 dysfunction in non-alcoholic steatohepatitis in mice and patients. | 2015 | Details |
| A21749 | 25072958 | Biochim Biophys Acta | A cell-type-specific role for murine Commd1 in liver inflammation. | 2014 | Details |
| A21751 | 25072708 | PLoS One | Identification of novel regulatory cholesterol metabolite, 5-cholesten, 3β,25-diol, disulfate. | 2014 | Details |
| A21759 | 25066109 | Diabetes Metab Res Rev | GLP-1 receptor agonists: effects on the progression of non-alcoholic fatty liver disease. | 2014 | Details |
| A21760 | 25065280 | Arch Iran Med | Regulation of adipokines by polyunsaturated fatty acids in a rat model of non-alcoholic steatohepatitis. | 2014 | Details |
| A21762 | 25063410 | J Ultrasound Med | Focal fatty sparing usually does not arise in preexisting nonalcoholic diffuse homogeneous fatty liver. | 2014 | Details |
| A21764 | 30258859 | Genes Dis | The molecular pathogenic role of inflammatory stress in dysregulation of lipid homeostasis and hepatic steatosis. | 2014 | Details |
| A21771 | 25057109 | J Mol Endocrinol | oxLDL induces injury and defenestration of human liver sinusoidal endothelial cells via LOX1. | 2014 | Details |
| A21772 | 25057104 | Nutrients | Pinus densiflora Sieb. et Zucc. alleviates lipogenesis and oxidative stress during oleic acid-induced steatosis in HepG2 cells. | 2014 | Details |
| A21777 | 25051240 | Metab Syndr Relat Disord | Evaluation of clinical and inflammatory markers of nonalcoholic fatty liver disease in postmenopausal women with metabolic syndrome. | 2014 | Details |
| A21780 | 25048953 | J Hepatol | Cyclophilin inhibition as potential therapy for liver diseases. | 2014 | Details |
| A21781 | 25048951 | J Hepatol | CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis. | 2014 | Details |
| A21782 | 25048611 | PLoS One | Inflammatory stress increases hepatic CD36 translational efficiency via activation of the mTOR signalling pathway. | 2014 | Details |
| A21787 | 25045276 | Clin Exp Gastroenterol | Molecular pathways in non-alcoholic fatty liver disease. | 2014 | Details |
| A21792 | 25043405 | Hepatology | Fructose leads to hepatic steatosis in zebrafish that is reversed by mechanistic target of rapamycin (mTOR) inhibition. | 2014 | Details |
| A21798 | 25038727 | Metabolism | Metabolically healthy obesity from childhood to adulthood - Does weight status alone matter? | 2014 | Details |
| A21805 | 25034283 | Dig Dis | The inflammasome in liver injury and non-alcoholic fatty liver disease. | 2014 | Details |
| A21812 | 25029454 | Curr Opin Cardiol | Should we expand the concept of coronary heart disease equivalents? | 2014 | Details |
| A21816 | 25024624 | World J Gastroenterol | Pro-atherosclerotic markers and cardiovascular risk factors one year after liver transplantation. | 2014 | Details |
| A21824 | 25024592 | World J Gastroenterol | Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesis. | 2014 | Details |
| A21827 | 25019921 | Dtsch Arztebl Int | Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment. | 2014 | Details |
| A21828 | 25019654 | Gen Comp Endocrinol | The effect of recombinant adeno-associated virus-adiponectin (rAAV2/1-Acrp30) on glycolipid dysmetabolism and liver morphology in diabetic rats. | 2014 | Details |
| A21838 | 25011936 | Gut | Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease. | 2014 | Details |